A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

NCT05317078 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor strategic decision

Conditions

Non-squamous Non-small Cell Lung Cancer
Epithelial Ovarian Cancer
Claudin 6-positive Advanced/Metastatic Malignant Solid Tumors

Interventions

DRUG: AMG 794

Sponsor

Amgen